Executive Leadership

THC Global Group Executive Personnel And Management

Ken Charteris Group Chief Executive Officer

Ken is a veteran of multiple biotech and pharmaceutical companies over the past three decades as CEO, Managing Director and Chairman. In previous Executive roles Ken has had full P&L and balance sheet responsibility including legal and financial compliance in listed and international structures, leading businesses with revenue exceeding $200m and asset bases within $100m - $500m. Ken has a proven track record in hands on roles within major listed international companies improving profit growth and effecting share price increase.

Ken was involved in various senior levels within THC since prior to listing on the ASX, Ken has been instrumental in the execution of the Company’s strategic plan, including the acquisition of THC’s manufacturing facility and the securing of commercial partnerships with Endoca (Europe). Ken has a specific mandate to drive future acquisitions and alliances for THC Global.

Dr Andrew Beehag Lead, Medicinal Cannabis Division

Andrew led the establishment of this business at its inception in 2016 including its successful licensing and partnership alliancing with Endoca and BOL Pharma and will continue to build THC’s successful investment and partnership strategy gearing up THC to supply to domestic patients and the export market in the near to medium term. Andrew’s key skills include creation and execution of strategic plans, operations and personnel management, intellectual property management and commercialisation, budgeting and financial forecasting, stakeholder negotiation and management, project management, public speaking and development of high performing teams.

Sonny DiduguHead of Corporate M&A

Sonny has significant corporate advisory, equity capital markets transactions, and listed entity compliance experience across a broad range of industry sectors including property development, gaming, fin-tech, esports, and cannabis. His past experience includes advisory roles within private equity houses, working within in-house counsel teams, and consulting to corporate advisory firms. Additionally, Sonny has previously acted for a wide range of ASX listed and unlisted entities providing investor relations support, equity market transactions advice, and general corporate and governance advisory services.

Sonny holds a Bachelor of Laws (Honours) and is a Member of the Australian Institute of Company Directors.

Angela MacquireChief Operating Officer - THC Pharma

Angela has over 30 years’ experience in the pharmaceutical industry including managerial and directorial roles at PCI Clinical Services, LEO Pharma, and IDT Australia as well as technical roles at GlaxoSmithKline and Pfizer. Angela’s experience includes managing the development and commercial manufacture of various pharmaceutical formulations both sterile and non-sterile, including nasal sprays, ointments, capsules, and tablets for Australian and North American clients to cGMP standards. Throughout her career, Angela has gained significant experience in early phase clinical trials.

Recently, Angela has also been involved in managing many medicinal cannabis formulations projects for global clients. This work has included formulation, manufacture and packaging of stable products for use in early phase clinical trials and Special Access Scheme use within the sector.

Jarrod WhiteChief Financial Officer

Jarrod is a Chartered Accountant and founding Director of Traverse Accountants Pty Ltd, a Corporate Advisory and Chartered Accounting Firm based in Sydney. Jarrod has been appointed Company Secretary and Chief Financial Officer of several other listed entities that operate on the Australian Stock Exchange and London Stock Exchange, and has a sound knowledge of corporate governance and compliance. Jarrod has also been an advisor to a wide range of capital raisings, IPO’s and reverse takeover transactions.

Laura HarveyChief Operating Officer - CANADA

Diandra PhippsChief Operating Officer - Tetra Health